Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis (vol 10, 811, 2020)
FRONTIERS IN ONCOLOGY(2021)
Key words
breast cancer,HER2,pyrotinib,tumor mutation burden,metastases
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined